Literature DB >> 21728900

Myocardial infarction induces early increased remote ADAM8 expression of rat hearts after cardiac arrest.

Vilma Vuohelainen1, Emma Raitoharju, Mari Levula, Terho Lehtimaki, Markku Pelto-Huikko, Teemu Honkanen, Ari Huovila, Timo Paavonen, Matti Tarkka, Ari Mennander.   

Abstract

BACKGROUND: A disintegrin and metalloproteinase-8 (ADAM8) is a potential surrogate of inflammation which has recently been associated with myocardial infarction. We evaluated in a rat cardiac transplantation model whether ischemia-reperfusion injury alone (IRI) or with early regional myocardial infarction (MI) would suffice to induce inflammatory myocardial remodeling and ADAM8 expression.
MATERIAL AND METHODS: Isogenic heterotopic cardiac transplantation after cardiac arrest was performed to 48 Fischer 344 rats to induce ischemia-reperfusion injury (IRI), of which 27 rats also underwent ligation of the left anterior coronary artery (LAD) of the heart to yield MI. Histology was performed at 0.5, 24 and 48 h after transplantation. ADAM8 was evaluated by qRT-PCR after graft harvesting.
RESULTS: After 0.5 and 48 h respectively, edematous intramyocardial artery nuclei and periadventitial inflammation were more prominent in MI after transplantation, as compared with IRI alone and Controls (57.0 vs 40.0 and 5.0; 1.9 vs 1.1 and 0.9, point score units, p < 0.05, respectively). The expression of ADAM-8 was increased in MI as compared with Controls (1.9 vs 1.0, 1.9 fold increase) at 48 h. In grafts with MI, ADAM8 was localized using immunohistochemistry to the vicinity of the area corresponding to the developing infarction as well as in intramyocardial arteries remote to the infarction area.
CONCLUSIONS: Remote histopathological changes of ischemic cardiac grafts are associated with increased expression of ADAM8 thus emphasizing a global myocardial impact of MI.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21728900     DOI: 10.3109/00365513.2011.591424

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  9 in total

Review 1.  A Disintegrin and Metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) family in vascular biology and disease.

Authors:  Sheng Zhong; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2019-03-21       Impact factor: 5.858

2.  Early reversibility of histological changes after experimental acute cardiac volume-overload.

Authors:  Christa Huuskonen; Mari Hämäläinen; Nooa Kivikangas; Timo Paavonen; Eeva Moilanen; Ari A Mennander
Journal:  Am J Cardiovasc Dis       Date:  2022-08-15

3.  ADAM and ADAMTS disintegrin and metalloproteinases as major factors and molecular targets in vascular malfunction and disease.

Authors:  HaiFeng Yang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2022-01-24

Review 4.  Contribution of ADAM17 and related ADAMs in cardiovascular diseases.

Authors:  Tatsuo Kawai; Katherine J Elliott; Rosario Scalia; Satoru Eguchi
Journal:  Cell Mol Life Sci       Date:  2021-02-11       Impact factor: 9.207

5.  Suppression of ADAM8 attenuates angiotensin II-induced cardiac fibrosis and endothelial-mesenchymal transition via inhibiting TGF-β1/Smad2/Smad3 pathways.

Authors:  Lixia Yao; Weihua Shao; Yan Chen; Suxing Wang; Dai Huang
Journal:  Exp Anim       Date:  2021-10-07

6.  Sevoflurane exerts improved protective effects than propofol on hypoxia-reoxygenation injury by regulating the microRNA-221-5p/ADAM8 axis in cardiomyocytes.

Authors:  Dan Xie; Huifei Deng; Hao Feng
Journal:  Exp Ther Med       Date:  2021-06-18       Impact factor: 2.447

7.  Oxytocin ameliorates the immediate myocardial injury in heart transplant through down regulation of the neutrophil dependent myocardial apoptosis.

Authors:  F Fadhil Al-Amran; Murteza Shahkolahi
Journal:  Heart Views       Date:  2014-04

8.  ADAM23 in Cardiomyocyte Inhibits Cardiac Hypertrophy by Targeting FAK - AKT Signaling.

Authors:  Mei Xiang; Hongbo Luo; Jia Wu; Lingyun Ren; Xiangchao Ding; Chuangyan Wu; Jiuling Chen; Shanshan Chen; Hao Zhang; Lu Yu; Yanqiang Zou; Heng Xu; Ping Ye; Manhua Chen; Jiahong Xia
Journal:  J Am Heart Assoc       Date:  2018-09-18       Impact factor: 5.501

9.  Novel genomic targets of valosin-containing protein in protecting pathological cardiac hypertrophy.

Authors:  Ning Zhou; Xin Chen; Jing Xi; Ben Ma; Christiana Leimena; Shaunrick Stoll; Gangjian Qin; Charles Wang; Hongyu Qiu
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.